Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × NIH × Leiomyoma × Clear all

Status

Completed 8 Terminated 1 Recruiting 1 Enrolling by invitation 1

Sponsor Class

OTHER 2 OTHER_GOV 1 NIH 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Prostatic Neoplasms 4 Neoplasms 4 Melanoma 4 Hematologic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Hematologic Diseases 2 Gastrointestinal Neoplasms 2 Carcinoma 2 Breast Neoplasms 2 Adenocarcinoma 2 von Hippel-Lindau Disease 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thrombocytopenia 1 Squamous Intraepithelial Lesions of the Cervix 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neutropenia 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, B-Cell 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05369611 2026-02-19

COVID-19 Experiences in the SELF Cohort

National Institutes of Health Clinical Center (CC)

Enrolling by invitation

COVID-19, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡